CLINICAL_TRIALS trial_result · 2026-02-24

Clinical Trial Update: Buspirone for the Treatment of Traumatic Brain Injury (TBI) Irritability and Aggression [Phase 4]

Phase 4 trial evaluating buspirone for irritability and aggression in traumatic brain injury has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Indiana University | Conditions: Traumatic Brain Injury | Phase 4 | Status: COMPLETED | Results posted: 2026-02-24